AWB Limited - 2004 Annual Report
AWB Limited - 2004 Annual Report
AWB Limited - 2004 Annual Report
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(h) Derivatives (continued)<br />
of the anticipated transaction when the transaction occurs as designated.<br />
Any gains or losses on the hedge transaction after that date are included<br />
in the statement of financial performance.<br />
The net amounts receivable or payable under forward foreign exchange<br />
contracts, open swaps, forward rate agreements and futures contracts<br />
and the associated deferred gains or losses are recorded on the statement<br />
of financial position from the date of inception of the hedge transaction.<br />
The net receivables or payables are revalued using the foreign currency,<br />
interest or commodity rates current at reporting date.<br />
When the anticipated transaction is no longer expected to occur as<br />
designated, the deferred gains and losses relating to the hedged<br />
transaction are recognised immediately in the statement of financial<br />
performance.<br />
Where a hedge transaction is terminated early and the anticipated<br />
transaction is still expected to occur as designated, the deferred gains and<br />
losses that arose on the hedge prior to its termination continue to be<br />
deferred and are included in the measurement of the purchase or sale or<br />
interest transaction when it occurs. Where a hedge transaction is<br />
terminated early because the anticipated transaction is no longer<br />
expected to occur as designated, deferred gains and losses that arose on<br />
the hedge prior to its termination are included in the statement of<br />
financial performance for the period.<br />
Where a hedge is redesignated as a hedge of another transaction, gains<br />
and losses arising on the hedge prior to its redesignation are only<br />
deferred where the original anticipated transaction is still expected to<br />
occur as designated. When the original anticipated transaction is no<br />
longer expected to occur as designated, any gains or losses relating to the<br />
hedge instrument are included in the statement of financial performance<br />
for the period.<br />
Other derivatives<br />
All other derivative transactions are initially recorded at the relevant rate<br />
at the date of the transaction. Derivatives outstanding at balance date are<br />
valued at the rates ruling on that date and any gains or losses are<br />
brought to account in the statement of financial performance. The<br />
exception is those interest rate derivatives detailed in Note 31(f ).<br />
(i) Cash<br />
For the purpose of the statement of cash flows, cash includes cash on<br />
hand and in banks, net of outstanding bank overdrafts. Bank overdrafts<br />
are carried at the principal amount. Interest is charged as an expense as<br />
it accrues.<br />
(j) Receivables<br />
The collectability of debts is assessed at balance date and specific<br />
provision is made for any doubtful accounts.<br />
Trade debtors<br />
Terms of trade receivables generally require settlement within 30 days.<br />
Receivables from related parties have been discounted to their present<br />
value using a market determined discount rate.<br />
(k) Inventories<br />
Inventories are valued at the lower of cost or net realisable value.<br />
Associates<br />
Investments in unlisted shares of associates are carried in the company's<br />
financial statements at the lower of cost or recoverable amount.<br />
Joint venture operations<br />
Investments in joint venture operations are accounted for in the<br />
financial statements as set out in Note 1(c) Principles of consolidation.<br />
Other entities<br />
Investments in other entities are carried at the lower of cost or<br />
recoverable amount.<br />
(m) Lease assets<br />
Finance leases<br />
Finance leases are capitalised. A lease asset and a lease liability equal to<br />
the present value of the minimum lease payments are recorded at the<br />
inception of the lease.<br />
Lease liabilities are reduced by repayments of principal. The interest<br />
components of the lease payments are expensed.<br />
Operating leases<br />
Payments made under operating leases are expensed on a straight line<br />
basis over the term of the lease.<br />
(n) Constructed non–current assets<br />
The cost of non–current assets constructed by the consolidated entity<br />
includes the cost of all materials used in construction, direct labour on<br />
the project and an appropriate proportion of overheads.<br />
(o) Research and development expenditure<br />
Research and development expenditure is expensed as incurred except to<br />
the extent that its recoverability is assured beyond any reasonable doubt,<br />
in which case it is deferred.<br />
(p) Intangible assets<br />
Goodwill<br />
On acquisition of some, or all, of the assets of another entity, the<br />
identifiable net assets acquired are measured at fair value. The excess of<br />
the fair value of the cost of acquisition over the fair value of the<br />
identifiable net assets acquired is brought to account as goodwill and<br />
will be amortised so that it is recognised as an expense in the statement<br />
of financial performance on a straight line basis over a period of 20 years<br />
or the expected useful life.<br />
Licence fees<br />
Costs associated with licence fees are deferred and amortised on a<br />
straight line basis over the period of their expected benefit.<br />
(q) Recoverable amount of non–current assets<br />
Non–current assets are not carried at an amount above their recoverable<br />
amount, and where carrying values exceed their recoverable amount,<br />
assets are written down to their recoverable amounts.<br />
(l) Investments<br />
Controlled entities<br />
Investments in controlled entities are carried in the company’s financial<br />
statements at the lower of cost or recoverable amount.<br />
65